- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
XBI
Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
Bet on Biogen Inc for Easy Profits Into the New Year
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI
Biotechnology investors have turned the equal-weight SPDR S&P Biotech ETF (XBI) into one of the largest sector plays. Is it right for you?
The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming — Get on Board
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios
Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock.
The Bulls’ Banner Waves in the SPDR S&P Biotech (ETF) (XBI)
The SPDR S&P Biotech ETF is forming a bull flag. Here's how to play biotech stocks for profit in XBI.
Dipping Celgene Corporation (CELG) Stock Is Begging to Be Bought
Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch.
Play the iShares Nasdaq Biotechnology Index (ETF)’s (IBB) Popularity for Free
ETFs should not move 11% in four days. The IBB just did that, so I will short it with no money out of pocket. Bet against the herd mentality.
Is the SPDR S&P Biotech (ETF) (XBI) Done Running?
Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading.
Trade of the Day: SPDR S&P Biotech (ETF) (XBI)
XBI hit a new 52-week high of $76.60 on Tuesday before easing back slightly to about $75. And I'm opting to employ one of my preferred bullish strategies here.
The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch
Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop.
Direxion Daily S&P Biotech Bear 3X Shares (LABD): The Quick Guide to LABD
Like other leveraged ETFs, Direxion Daily S&P Biotech Bear 3X Shares (LABD) seduces with big potential gains when biotech stocks drop.
How to Profit From the Bulls’ Return to Biotech Stocks (XBI)
Biotech stocks are making a comeback. Use this bullish XBI play to capitalize on continued strength in the sector.